RVPH — Reviva Pharmaceuticals Holdings,. Balance Sheet
0.000.00%
Last trade - 00:00
- $39.71m
- $33.74m
2019 February 28th | 2020 February 29th | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.313 | 0.069 | 29.7 | 18.5 | 23.4 |
Prepaid Expenses | |||||
Total Current Assets | 0.404 | 0.139 | 31.4 | 18.9 | 23.7 |
Long Term Investments | |||||
Total Assets | 65.6 | 61 | 31.4 | 18.9 | 23.7 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.023 | 0.3 | 2.34 | 9.96 | 17.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.24 | 3.26 | 2.72 | 10.5 | 18 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 63.4 | 57.8 | 28.7 | 8.39 | 5.72 |
Total Liabilities & Shareholders' Equity | 65.6 | 61 | 31.4 | 18.9 | 23.7 |
Total Common Shares Outstanding |